Asan Medical Center (AMC)
Seoul 5505
6 studies enrolling now · 7 studies all time
What they study most
Breast Neoplasms, Crohn's Disease, Extensive-stage Small-cell Lung Cancer, MET Alteration, Neoplasms, Non-small Cell Lung Cancer, Solid Tumor, Ulcerative Colitis
Studies at this site
- ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer — Recruiting now
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
- Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
- FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations — Recruiting now
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling